Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin.

Article Details

Citation Copy to clipboard

Premkumar VG, Yuvaraj S, Vijayasarathy K, Gangadaran SG, Sachdanandam P

Basic Clin Pharmacol Toxicol. 2007 Jun;100(6):387-91.

PubMed ID

17516992 [ View in PubMed

]

Abstract

The prognostic significance of supplementing co-enzyme Q(10) (CoQ(10)), riboflavin and niacin (CoRN) along with tamoxifen to breast cancer patients was evaluated by measuring the serum cytokine levels of interleukin (IL)-1beta, IL-6, IL-8, tumour necrosis factor alpha (TNF-alpha) and vascular endothelial growth factor. In the present study, 84 breast cancer patients were randomized to receive a daily supplement of CoQ(10) 100 mg, riboflavin 10 mg and niacin 50 mg, one dosage per day along with tamoxifen 10 mg twice a day. Serum cytokine levels were elevated in untreated breast cancer patients (Group II) and significantly reduced after tamoxifen therapy for more than 1 year (Group III). When group III breast cancer patients were supplemented with CoRN for 45 days (Group IV) and 90 days (Group V) along with tamoxifen, a significant reduction in cytokine levels were observed (P < 0.05). Such a decrease in serum cytokine levels after CoRN supplementation in breast cancer patients may suggest good prognosis and efficacy of the treatment, and might even offer protection from metastases and recurrence of cancer.

DrugBank Data that Cites this Article

Pharmaco-proteomics

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome
Tamoxifen	Approved	CXCL8	3576	decreased	Tamoxifen results in decreased expression of CXCL8 protein	4q13.3
Tamoxifen	Approved	IL1B	3553	decreased	Tamoxifen results in decreased expression of IL1B protein	2q14.1
Tamoxifen	Approved	IL6	3569	decreased	Tamoxifen results in decreased expression of IL6 protein	7p15.3
Tamoxifen	Approved	TNF	7124	decreased	Tamoxifen results in decreased expression of TNF protein	6p21.33